Piper Jaffray Starts Transcept Pharmaceuticals (TSPT) at Overweight
Tweet Send to a FriendGet Alerts TSPT Hot Sheet
Price: $3.16 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 21 | Down: 43 | New: 13
Trade TSPT Now!
Piper Jaffray initiates coverage on Transcept Pharmaceuticals (NASDAQ: TSPT) with a Overweight. PT $8.00.
For an analyst ratings summary and ratings history on Transcept Pharmaceuticals click here. For more ratings news on Transcept Pharmaceuticals click here.
Shares of Transcept Pharmaceuticals closed at $4.74 yesterday, with a 52 week range of $4.10-$12.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Transcept Pharmaceuticals click here. For more ratings news on Transcept Pharmaceuticals click here.
Shares of Transcept Pharmaceuticals closed at $4.74 yesterday, with a 52 week range of $4.10-$12.99.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
- Piper Jaffray Starts Hasbro (HAS) at Overweight
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Piper Jaffray
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
